Tribulus Terrestris — Research Profile

No. Despite being marketed as a testosterone booster for decades, multiple well-controlled human studies show tribulus has no significant effect on testosterone, LH, FSH, or DHT in healthy men. The confusion arose from animal studies where tribulus did raise androgens, but these results do not translate to humans. If your testosterone is truly low, see a doctor — no OTC supplement meaningfully raises testosterone.

Some users report improved libido or energy, which may be due to non-hormonal mechanisms (possible effects on androgen receptor sensitivity, nitric oxide, or dopamine), placebo effect, or the general adaptogenic properties of the plant. These subjective improvements occur without measurable changes in hormone levels.

Evidence-based strategies include: adequate sleep (7-9 hours), resistance training, maintaining healthy body fat (12-20% for men), sufficient vitamin D (2000-5000 IU/day if deficient), adequate zinc (15-30 mg/day if deficient), stress management, and limiting alcohol. No legal OTC supplement meaningfully raises testosterone in healthy eugonadal men.

Trials have used fruit or aerial-part extracts standardized to steroidal saponins, taken as tablets or capsules; no study has directly compared different forms, sources, or extraction methods head-to-head. Because none of these standardized forms reliably raised testosterone in men, "best form" is not a settled question. Whole-herb powders and standardized extracts have not been shown to differ meaningfully in clinical effect.

The best-supported effect is a modest improvement in erectile function: a 2025 meta-analysis of 8 trials found higher scores versus placebo (IIEF-5 mean difference 3.23). Reviews also report improved sperm number, motility and morphology in idiopathic infertility (6 of 7 studies) and higher sexual-function scores in women, though on very-low-certainty evidence. Critically, it does not reliably raise testosterone, and reviews conclude that testosterone-boosting marketing claims are unsubstantiated.

Erectile-dysfunction trials used 400 to 750 mg per day for 1 to 3 months, and LiverTox lists a usual daily dose of 250 to 750 mg. No single optimal dose is established, and higher intakes carry the organ-injury risk flagged in case reports. Some early studies divided the daily amount across three intakes rather than one.

Time of day has not been directly compared in Tribulus trials. Study protocols simply dosed it daily — sometimes as a single dose, sometimes divided into three intakes — with no data suggesting morning versus evening changes the outcome. Taking it with food may blunt the mild stomach upset some users report.

The most commonly reported effects are mild: gastrointestinal discomfort, nausea or dyspepsia. In the erectile-dysfunction meta-analysis, adverse-event rates did not differ between Tribulus and placebo. Rare but serious case reports of liver and kidney injury exist, mainly with high doses or pre-existing organ disease.

No well-documented drug interactions have been established in clinical studies, and the LiverTox monograph does not list specific interacting medications. Given case reports of liver and kidney injury, caution is reasonable if you take other drugs that stress the liver or kidneys, or already have liver or kidney disease. Because reliable interaction data are lacking, this is an area of genuine uncertainty rather than demonstrated safety.

The clearest candidates are men with erectile dysfunction seeking a modest adjunct, men with idiopathic infertility (where sperm parameters improved in most studies), and women with sexual dysfunction — though the evidence is low-certainty. It is not an effective testosterone booster: controlled trials in young men and athletes showed no rise in androgens or strength beyond placebo. People with liver or kidney disease should avoid it given the case-report signal.

Trials rarely measure onset directly, but studies reporting improved erectile function or female sexual-function scores dosed Tribulus for 1 to 3 months before assessing endpoints, and a rugby-player strength trial ran 5 weeks. So any effect should be judged over several weeks, not days. Because it does not measurably raise testosterone in most people, expecting a rapid "test-boost" is not evidence-based.

Human trials have generally lasted only 1 to 3 months, so daily use beyond that has not been formally studied. The NIH LiverTox monograph describes Tribulus as usually well tolerated but rates it E* — an unproven but possible rare cause of clinically apparent liver injury at high doses or in people with pre-existing liver disease. A review in physically active adults reported no Tribulus-induced toxicity over the studied periods, but longer-term safety remains unestablished.

There is no established tolerable upper limit for Tribulus. Supplements typically come as 250 or 500 mg tablets with usual daily doses of 250 to 750 mg, and LiverTox notes higher doses should be considered potentially injurious, especially with pre-existing liver disease or cirrhosis. Isolated case reports describe severe liver and kidney injury, so exceeding label doses is not advisable.

A systematic review found that testosterone increases appeared in humans only when Tribulus was given as part of a combined supplement, never on its own, making it hard to credit Tribulus itself for any effect. It is commonly stacked into commercial "sexual health" blends, but doing so also compounds overlapping gastrointestinal and potential liver risks. No trial has shown that a particular combination is safer or more effective than a single well-characterized ingredient.

Look for extracts standardized to steroidal saponins (often labeled by protodioscin content), the constituents used in trials, and treat "Bulgarian" sourcing as marketing rather than a quality guarantee. Be skeptical of testosterone claims: even standardized extracts failed to raise androgen levels in controlled studies of young men. Given case reports of organ injury from high-dose or adulterated products, independent third-party testing matters more than a headline saponin percentage.